Neutra Looking Into Medical and Recreational Cannabis Market as Legislative Outlook Improves
KATY, TX / ACCESSWIRE / February 26, 2021 / Neutra Corp. (OTC PINK:NTRR) (“Neutra” or “the Company”) is considering a move into the medical and recreational cannabis arena as states relax their prohibitions against the substance. Neutra notes that New Jersey Gov. Phil Murphy this week signed a bill that legalizes recreational cannabis use for adults, completing a three-year legislative journey. Fifteen states have now fully legalized cannabis use, opening a large potential market for CBD companies like Neutra and its subsidiary VIVIS.
“This is a natural, logical step for our company as we continue to grow,” said Neutra CEO Sydney Jim. “Just eight states of 50 now don’t allow for any use, even medicinal, so attitudes towards cannabis have dramatically changed. There’s tremendous market potential, and more people will want to try cannabis-based CBD products once legal barriers and penalties have been removed. It’s definitely worth exploring.”
All of Neutra’s executive management team and most of its operational staff have extensive backgrounds in multiple medicinal cannabis verticals. This experience includes cultivation and production, corporate structure, accounting, distribution, and more.
As of February 2021, several large, populous states have fully legalized cannabis for both recreational and medicinal use, and decriminalized its possession and sale. These include the aforementioned New Jersey plus California, Washington and Illinois. New York and Ohio permit medicinal marijuana and have decriminalized possession, but do not allow recreational use. Others, such as Texas, Florida and Pennsylvania allow for some sort of medicinal use (such as CBD oils, in Texas’ case), but ban recreational cannabis and have not decriminalized it.
Industry watchers expect New York, Virginia and New Mexico to be among the next states to legalize all cannabis use.
About Neutra Corp.
Neutra Corp. (OTC PINK:NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at http://www.NeutraInc.com.
NOTICE REGARDING FORWARD-LOOKING STATEMENTS
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp.
View source version on accesswire.com:
https://www.accesswire.com/632351/NeutraLooking-Into-Medical-and-Recreational-Cannabis-Market-as-Legislative-Outlook-Improves
